Infective endocarditis: Difference between revisions
From IDWiki
(→: gave organism list more structure) |
(→) |
||
| Line 6: | Line 6: | ||
** ''[[Staphylococcus aureus]]'' |
** ''[[Staphylococcus aureus]]'' |
||
** [[Viridans group streptococci]] |
** [[Viridans group streptococci]] |
||
** [[Coagulase-negative |
** [[Coagulase-negative Staphylococci]] |
||
** Other streptococci |
** Other streptococci |
||
** [[Enterococci]] |
** [[Enterococci]] |
||
Revision as of 23:21, 19 August 2019
- Infection of heart valves
Organisms
- Bacteria
- Fungi
Presentation
- Modified Duke criteria
- IVDU: Viridans group streptococci and Pseudomonas aeroginosa
- Colon cancer: Streptococcus bovis and Clostridium septicum
Treatment
- MSSA native valve endocarditis
- MSSA prosthetic valve endocarditis
- Cloxacillin PLUS rifampin PLUS 2 weeks of gentamicin
- OR Vancomycin/Daptomycin, other things
- 6 weeks
References
- ^ Kasper Iversen, Nikolaj Ihlemann, Sabine U. Gill, Trine Madsen, Hanne Elming, Kaare T. Jensen, Niels E. Bruun, Dan E. Høfsten, Kurt Fursted, Jens J. Christensen, Martin Schultz, Christine F. Klein, Emil L. Fosbøll, Flemming Rosenvinge, Henrik C. Schønheyder, Lars Køber, Christian Torp-Pedersen, Jannik Helweg-Larsen, Niels Tønder, Claus Moser, Henning Bundgaard. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis. New England Journal of Medicine. 2019;380(5):415-424. doi:10.1056/nejmoa1808312.
- ^ John A Wildenthal, Andrew Atkinson, Sophia Lewis, Sena Sayood, Nathanial S Nolan, Nicolo L Cabrera, Jonas Marschall, Michael J Durkin, Laura R Marks. Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs. Clinical Infectious Diseases. 2022;76(3):487-496. doi:10.1093/cid/ciac714.
- ^ Sarah Freling, Noah Wald-Dickler, Josh Banerjee, Catherine P Canamar, Soodtida Tangpraphaphorn, Dara Bruce, Kusha Davar, Fernando Dominguez, Daniel Norwitz, Ganesh Krishnamurthi, Lilian Fung, Ashley Guanzon, Emi Minejima, Michael Spellberg, Catherine Spellberg, Rachel Baden, Paul Holtom, Brad Spellberg. Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort Study. Clinical Infectious Diseases. 2023;77(5):672-679. doi:10.1093/cid/ciad119.
